sec filing
RP
NASDAQ · RPID
Rapid Micro Biosystems, Inc.
Healthcare · Medical - Devices
$1.15
Down-$0.02 (-1.71%)
Updated Sep 16, 2026, 10:03 AM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 164.95M
- P/E ratio
- -3.74
- Dividend yield
- 0.00%
- 52-week range
- $1.16 – $4.47
- Volume
- 213.11K
- Avg. volume
- 97.66K
Price performance
RPID price history
1M range · 20 trading sessions · Daily adjusted prices
RPID closed at $1.15 after 20 trading sessions, down 26.28% for the selected period.
- Last close
- $1.15
- Period change
- -26.28%
- Period low
- $1.15
- Period high
- $1.70
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.19 | $1.19 | $1.13 | $1.15 | 213.11K |
| Sep 14, 2026 | $1.23 | $1.23 | $1.155 | $1.17 | 172.36K |
| Sep 11, 2026 | $1.22 | $1.26 | $1.20 | $1.23 | 205.7K |
| Sep 10, 2026 | $1.20 | $1.2372 | $1.16 | $1.20 | 385.17K |
| Sep 9, 2026 | $1.24 | $1.255 | $1.18 | $1.21 | 409.34K |
| Sep 8, 2026 | $1.33 | $1.385 | $1.22 | $1.22 | 312.44K |
| Sep 4, 2026 | $1.37 | $1.49 | $1.29 | $1.31 | 378.83K |
| Sep 3, 2026 | $1.41 | $1.43 | $1.34 | $1.38 | 107.26K |
| Sep 2, 2026 | $1.49 | $1.53 | $1.38 | $1.39 | 204.98K |
| Sep 1, 2026 | $1.53 | $1.53 | $1.47 | $1.50 | 167.55K |
| Aug 31, 2026 | $1.60 | $1.6132 | $1.48 | $1.52 | 198.81K |
| Aug 28, 2026 | $1.62 | $1.63 | $1.55 | $1.57 | 70.02K |
| Aug 27, 2026 | $1.67 | $1.68 | $1.61 | $1.61 | 134.5K |
| Aug 26, 2026 | $1.67 | $1.7199 | $1.60 | $1.67 | 91.09K |
| Aug 25, 2026 | $1.67 | $1.69 | $1.60 | $1.66 | 186.64K |
| Aug 24, 2026 | $1.68 | $1.71 | $1.62 | $1.66 | 200.53K |
| Aug 21, 2026 | $1.69 | $1.705 | $1.635 | $1.68 | 122.66K |
| Aug 20, 2026 | $1.70 | $1.74 | $1.64 | $1.67 | 323.18K |
| Aug 19, 2026 | $1.60 | $1.74 | $1.57 | $1.70 | 297.24K |
| Aug 18, 2026 | $1.57 | $1.64 | $1.52 | $1.56 | 94.91K |
Latest RPID news
The latest Smart Investors Daily articles mentioning RPID.
Stock researchCompany · Overview
RPID research
Overview
Company profile and research snapshot.
Company profile
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $8.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 29, 2026 | Keybanc | Overweight | — |
| May 22, 2026 | Lake Street | Buy | — |
| Jul 28, 2025 | Lake Street | Buy | — |
| Feb 12, 2025 | Keybanc | Overweight | — |
| Mar 7, 2023 | Morgan Stanley | Equal-Weight | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.